Advanced search
Publication Cover
Pediatric Hematology and Oncology Volume 36, 2019 - Issue 7
Submit an article Journal homepage
258
Views
0
CrossRef citations to date
0
Altmetric
Reports

Potassium supplementation mitigates corticosteroid-induced neuropsychiatric effects in pediatric oncology patients

Holly PariuryUCSF Benioff Children’s Hospital Oakland, Oakland, California, USACorrespondence[email protected]
View further author information
,
John WillhoiteUCSF Benioff Children’s Hospital Oakland, Oakland, California, USAView further author information
,
Jennifer MichlitschUCSF Benioff Children’s Hospital Oakland, Oakland, California, USAView further author information
&
Anurag AgrawalUCSF Benioff Children’s Hospital Oakland, Oakland, California, USAView further author information
Pages 445-450 | Received 12 Apr 2019, Accepted 20 Aug 2019, Published online: 05 Sep 2019

References

  • McGrath P, Rawson-Huff N. Corticosteroids during continuation therapy for acute lymphoblastic leukemia: the psycho-social impact. Issues Compr Pediatr Nurs. 2010; 33:5–19. doi: 10.3109/01460860903486572.
  • Mrakotsky CM, Silverman LB, Dahlberg SE, et al. Neurobehavioral side effects of corticosteroids during active treatment for acute lymphoblastic leukemia in children are age-dependent: report from Dana-Farber Cancer Institute ALL Consortium protocol 00-01. Pediatr Blood Cancer. 2011;57:492–498. doi: 10.1002/pbc.23060.
  • Drozdowicz LB, Bostwick LM. Psychiatric adverse effects on pediatric corticosteroid use. Mayo Clin Proc. 2014;89:817–834. doi: 10.1016/j.mayocp.2014.01.010.
  • Stuart FA, Segal TY, Keady SS. Adverse psychological effects of corticosteroids in children and adolescents. Arch Dis Child. 2005;90:500–506. doi: 10.1136/adc.2003.041541.
  • Tavassoli N, Montastruc-Fournier J, Montastruc JL. Psychiatric adverse drug reactions to glucocorticoids in children and adolescents: a much higher risk with elevated doses. Br J Clin Pharmacol. 2008;66:566–567. doi: 10.1111/j.1365-2125.2008.03219.x.
  • Warrington TP, Bostwick JM. Psychiatric adverse effects of corticosteroids. Mayo Clin Proc. 2006;81:1361–1367. doi: 10.4065/81.10.1361.
  • Lewis DA, Smith RE. Steroid-induced psychiatric syndromes. A report of 14 cases and a review of the literature. J Affect Disord. 1983;5:319–332. doi: 10.1016/0165-0327(83)90022-8.
  • Hall RC, Popkin MK, Stickney SK, et al. Presentation of the steroid psychoses. J Nerv Ment Dis. 1979;167:229–236. doi: 10.1097/00005053-197904000-00006.
  • Mitchell CD, Richards SM, Kinsey SE, et al. Benefit of dexamethasone compared with prednisolone for childhood acute lymphoblastic leukaemia: results of the UK Medical Research Council ALL97 randomized trial. Br J Haematol. 2005;129:734–745. doi: 10.1111/j.1365-2141.2005.05509.x.
  • Bostrom BC, Sensel MR, Sather HN, et al. Dexamethasone versus prednisone and daily oral versus weekly intravenous mercaptopurine for patients with standard-risk acute lymphoblastic leukemia: a report from the Children’s Cancer Group. Blood. 2003;101:3809–3817. doi: 10.1182/blood-2002-08-2454.
  • Pui CH. Childhood Leukemias, 3rd ed. Cambridge, NY: Cambridge University Press; 2012. 352.
  • Corkins M, Balint J. The A.S.P.E.N Pediatric Nutrition Support Core Curriculum. Silver Spring, MD: American Society of Parenteral and Enteral Nutrition; 2010.
  • Kliegman R, Nelson W. Nelson Textbook of Pediatrics. 19th ed. Philadelphia, PA: Saunders Elsevier; 2011. 357.
  • Kuo PH, Chuang LC, Liu JP, et al. Identification of novel loci for bipolar I disorder in a multi-stage genome-wide association study. Prog Neuropsychopharmacol Biol Psychiatry. 2014;51:58–64. doi: 10.1016/j.pnpbp.2014.01.003.
  • Judy JT, Seifuddin F, Pirooznia M, et al. Converging evidence for epistasis between ANK3 and potassium channel gene KCNQ2 in bipolar disorder. Front Genet. 2013;4:87.
  • Kato T. Whole genome/exome sequencing in mood and psychotic disorders. Psychiatry Clin Neurosci. 2015;69:65–76. doi: 10.1111/pcn.12247.
  • Heurteaux C, Lucas G, Guy N, et al. Deletion of the background potassium channel TREK-1 results in a depression-resistant phenotype. Nat Neurosci. 2006;9:1134–1141. doi: 10.1038/nn1749.
  • Pelletier G, Lacroix Y, Moghrabi A, et al. Double-blind crossover study of chlorpromazine and lorazepam in the treatment of behavioral problems during treatment of children with acute lymphoblastic leukaemia receiving glucocorticoids. Med Pediatr Oncol. 2000;34:276–277.
  • Warris TL, van den Heuvel-Eibrink MM, Aarsen FK, et al. Hydrocortisone as an intervention for dexamethasone-induced adverse effects in pediatric patients with acute lymphoblastic leukemia: results of a double-blind, randomized control trial. JCO. 2016;34:2287–2293. doi: 10.1200/JCO.2015.66.0761.
  • Hochhauser CJ, Lewis M, Kamen BA, et al. Steroid-induced alterations of mood and behavior in children during treatment for acute lymphoblastic leukemia. Support Care Cancer. 2005;13:967–974. doi: 10.1007/s00520-005-0882-8.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.